ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China
· Delayed Price · Currency is CNY 41.23
+0.87 (2.16%)
Apr 29, 2026, 4:00 PM EDT
ChengDa Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2019 |
| Cash & Equivalents | 431.1 | 725.8 | 178.46 | 1,364 | 604.43 | 18.49 | Upgrade
|
| Trading Asset Securities | 533.04 | 270.08 | 957.65 | - | 776.89 | - | Upgrade
|
| Cash & Short-Term Investments | 964.14 | 995.88 | 1,136 | 1,364 | 1,381 | 18.49 | Upgrade
|
| Cash Growth | -11.60% | -12.34% | -16.70% | -1.26% | 7369.47% | -60.67% | Upgrade
|
| Accounts Receivable | 141.78 | 111.33 | 97.75 | 126.68 | 111.13 | 93.08 | Upgrade
|
| Other Receivables | 0.52 | 0.42 | 0.17 | 0.19 | 0.01 | 0.49 | Upgrade
|
| Receivables | 142.3 | 111.74 | 97.92 | 126.87 | 111.14 | 93.56 | Upgrade
|
| Inventory | 146.85 | 148.43 | 135.27 | 130.47 | 156.43 | 104.18 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 4.02 | Upgrade
|
| Other Current Assets | 47.73 | 48.24 | 45.86 | 21.59 | 30.88 | 5.67 | Upgrade
|
| Total Current Assets | 1,301 | 1,304 | 1,415 | 1,643 | 1,680 | 225.93 | Upgrade
|
| Property, Plant & Equipment | 821.15 | 839 | 872.25 | 646.21 | 518.45 | 402.21 | Upgrade
|
| Long-Term Investments | 66.71 | 68.48 | 7.41 | 30 | 30 | - | Upgrade
|
| Other Intangible Assets | 37.37 | 37.16 | 36.51 | 33.85 | 34.58 | 39.83 | Upgrade
|
| Long-Term Deferred Tax Assets | 13.98 | 13.34 | 8.06 | 4.29 | 4.23 | 2.79 | Upgrade
|
| Long-Term Deferred Charges | 44.32 | 48.92 | 44.12 | 43.5 | 12.93 | 6.47 | Upgrade
|
| Other Long-Term Assets | 47.65 | 38.68 | 52.94 | 54.6 | 41.95 | 6 | Upgrade
|
| Total Assets | 2,332 | 2,350 | 2,436 | 2,455 | 2,322 | 683.23 | Upgrade
|
| Accounts Payable | 142.47 | 164.63 | 189.23 | 139.89 | 77.82 | 57.83 | Upgrade
|
| Accrued Expenses | 5.43 | 7.17 | 11.96 | 9.71 | 10.76 | 6.84 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 54.06 | Upgrade
|
| Current Portion of Long-Term Debt | 14.81 | 14.81 | - | - | - | 15 | Upgrade
|
| Current Income Taxes Payable | 0.49 | 8.51 | 0.1 | 5.63 | 0.04 | 4.87 | Upgrade
|
| Current Unearned Revenue | 4.89 | 3.35 | 2.79 | 11.87 | 6.18 | 7.82 | Upgrade
|
| Other Current Liabilities | 3.69 | 4.49 | 2.69 | 4.43 | 4.74 | 1.37 | Upgrade
|
| Total Current Liabilities | 171.77 | 202.97 | 206.76 | 171.53 | 99.54 | 147.78 | Upgrade
|
| Long-Term Debt | 44.3 | 44.3 | 80.12 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 10.84 | 4.72 | 2.51 | 3.43 | 4.47 | 5.52 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.21 | 0.85 | 1.38 | 1.44 | 1.8 | - | Upgrade
|
| Total Liabilities | 228.13 | 252.83 | 290.77 | 176.4 | 105.81 | 153.3 | Upgrade
|
| Common Stock | 154.71 | 154.71 | 154.71 | 154.71 | 96.7 | 72.52 | Upgrade
|
| Additional Paid-In Capital | 1,694 | 1,694 | 1,694 | 1,693 | 1,751 | 152.57 | Upgrade
|
| Retained Earnings | 335.46 | 328.46 | 370.68 | 429.09 | 367.12 | 304.15 | Upgrade
|
| Treasury Stock | -57.07 | -57.07 | -57.07 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -25.5 | -25.5 | -19.2 | - | - | - | Upgrade
|
| Total Common Equity | 2,101 | 2,094 | 2,143 | 2,277 | 2,214 | 529.24 | Upgrade
|
| Minority Interest | 2.63 | 2.61 | 2.64 | 1.8 | 1.68 | 0.68 | Upgrade
|
| Shareholders' Equity | 2,104 | 2,097 | 2,146 | 2,279 | 2,216 | 529.93 | Upgrade
|
| Total Liabilities & Equity | 2,332 | 2,350 | 2,436 | 2,455 | 2,322 | 683.23 | Upgrade
|
| Total Debt | 59.11 | 59.11 | 80.12 | - | - | 69.06 | Upgrade
|
| Net Cash (Debt) | 905.02 | 936.77 | 1,056 | 1,364 | 1,381 | -50.56 | Upgrade
|
| Net Cash Growth | -9.72% | -11.29% | -22.58% | -1.26% | - | - | Upgrade
|
| Net Cash Per Share | 5.98 | 6.18 | 6.95 | 8.82 | 9.12 | -0.44 | Upgrade
|
| Filing Date Shares Outstanding | 151.56 | 151.58 | 151.47 | 154.71 | 154.71 | 116.04 | Upgrade
|
| Total Common Shares Outstanding | 151.56 | 151.58 | 151.47 | 154.71 | 154.71 | 116.04 | Upgrade
|
| Working Capital | 1,129 | 1,101 | 1,208 | 1,471 | 1,580 | 78.15 | Upgrade
|
| Book Value Per Share | 13.87 | 13.82 | 14.15 | 14.72 | 14.31 | 4.56 | Upgrade
|
| Tangible Book Value | 2,064 | 2,057 | 2,107 | 2,243 | 2,180 | 489.41 | Upgrade
|
| Tangible Book Value Per Share | 13.62 | 13.57 | 13.91 | 14.50 | 14.09 | 4.22 | Upgrade
|
| Buildings | - | - | 325.77 | 256.48 | 227.07 | 184.8 | Upgrade
|
| Machinery | - | - | 701.73 | 430.36 | 328.86 | 313.05 | Upgrade
|
| Construction In Progress | - | - | 101.46 | 179.17 | 153.53 | 70.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.